ArticleFrontiers in microbiology2025
Polymyxin-resistant hypervirulent
Article in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Isolation and identification of Klebsiella pneumoniae from Tibetan pigs and preparation of inactivated vaccine with Tibetan medicine adjuvant.BMC veterinary research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Polymyxins are critical last-resort treatments for infections caused by multidrug-resistant (MDR) gram-negative bacteria, especially carbapenem-resistant isolates. Recently, there has been a continuous increase in reports of polymyxin-resistant Methods: In this study, 17 PoRKP strains were retrospectively identified from 2,146 Results: The overall polymyxin resistance rate among the bacterial isolates included in this study was low (0.8%); however, all PoRKP isolates were MDR-positive. Notably, only three isolates carried Conclusion: Our findings indicated a relatively low prevalence of plasmid-mediated mobile polymyxin resistance genes among PoRKP isolates, whereas the upregulation of the two-component systems (particularly phoPQ) played a more prominent role in mediating polymyxin resistance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.